SCHEMBL7725083

SCHEMBL7725083

O=C(NC1CCN(CCc2ccc(F)cc2)C1)C1C2CC3C[C@@H]1CN(C3)C2

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.46
HTR2C P28335 3/20 0.46
HTR7 P34969 3/20 0.46
HTR6 P50406 2/20 0.46
CCR3 P51677 2/20 0.44
CACNA1G O43497 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
XIAP P98170 1/20 0.42
BIRC2 Q13490 1/20 0.42
SIGMAR1 Q99720 3/20 0.41
NR4A2 P43354 1/20 0.41
KCNH2 Q12809 1/20 0.41
SSTR5 P35346 1/20 0.41
EED O75530 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7725077 1.00 HTR2A (0.46) HTR2AHTR2CHTR7HTR6CCR3
SCHEMBL7725075 1.00 HTR2A (0.46) HTR2AHTR2CHTR7HTR6CCR3
SCHEMBL7724046 0.89 SIGMAR1 (0.54) HTR2ADRD2DRD4SIGMAR1
SCHEMBL7724049 0.89 SIGMAR1 (0.54) HTR2ADRD2DRD4SIGMAR1
SCHEMBL7724053 0.89 SIGMAR1 (0.54) HTR2ADRD2DRD4SIGMAR1
SCHEMBL7729553 0.89 HTR2A (0.52) HTR2AHTR2CHTR7HTR6CCR3
SCHEMBL7729559 0.89 HTR2A (0.52) HTR2AHTR2CHTR7HTR6CCR3
SCHEMBL7719856 0.85 HTR2A (0.43) HTR2AHTR2CHTR7HTR6CCR3
SCHEMBL7719855 0.85 HTR2A (0.43) HTR2AHTR2CHTR7HTR6CCR3
SCHEMBL7719806 0.83 HTR2A (0.51) HTR2AHTR2CHTR7HTR6CCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468998-B1 ANTAGONIZE SEROTONIN 2 RECEPTORS, SUPPRESS PLATELET AGGREGATION, IMPROVE PERIPHERAL CIRCULATION AND PROMOTE LACHRYMATION MITSUBISHI PHARMA CORPORATION (JP) 2002-10-22 US disclosed
EP-1125922-A1 PYRROLIDINE COMPOUNDS AND MEDICINAL UTILIZATION THEREOF Welfide Corporation (JP) 2001-08-22 EP disclosed